ID   CALM1_RAT               Reviewed;         149 AA.
AC   P0DP29; P02593; P62161; P70667; P99014; Q61379; Q61380;
DT   10-MAY-2017, integrated into UniProtKB/Swiss-Prot.
DT   10-MAY-2017, sequence version 1.
DT   26-FEB-2020, entry version 29.
DE   RecName: Full=Calmodulin-1 {ECO:0000250|UniProtKB:P0DP23};
GN   Name=Calm1 {ECO:0000312|RGD:2257};
GN   Synonyms=Calm, Cam, Cam1, CaMI {ECO:0000303|PubMed:3035194};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Brain;
RX   PubMed=3035194; DOI=10.1016/0022-2836(87)90258-0;
RA   Nojima H., Hirofumi S.;
RT   "Structure of a gene for rat calmodulin.";
RL   J. Mol. Biol. 193:439-445(1987).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Wistar; TISSUE=Brain;
RX   PubMed=1315919; DOI=10.1016/0169-328x(92)90039-e;
RA   Ni B., Rush S., Gurd J.W., Brown I.R.;
RT   "Molecular cloning of calmodulin mRNA species which are preferentially
RT   expressed in neurons in the rat brain.";
RL   Brain Res. Mol. Brain Res. 13:7-17(1992).
RN   [3]
RP   PROTEIN SEQUENCE OF 2-149, ACETYLATION AT ALA-2, AND METHYLATION AT
RP   LYS-116.
RC   TISSUE=Testis;
RX   PubMed=201628;
RA   Dedman J.R., Jackson R.L., Schreiber W.E., Means A.R.;
RT   "Sequence homology of the Ca2+-dependent regulator of cyclic nucleotide
RT   phosphodiesterase from rat testis with other Ca2+-binding proteins.";
RL   J. Biol. Chem. 253:343-346(1978).
RN   [4]
RP   PROTEIN SEQUENCE OF 15-31; 79-87 AND 92-107, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RC   STRAIN=Sprague-Dawley; TISSUE=Brain, and Hippocampus;
RA   Lubec G., Chen W.-Q., Kang S.U., Lubec S.;
RL   Submitted (SEP-2007) to UniProtKB.
RN   [5]
RP   INTERACTION WITH CEACAM1.
RX   PubMed=8576129; DOI=10.1074/jbc.271.3.1393;
RA   Edlund M., Blikstad I., Obrink B.;
RT   "Calmodulin binds to specific sequences in the cytoplasmic domain of C-CAM
RT   and down-regulates C-CAM self-association.";
RL   J. Biol. Chem. 271:1393-1399(1996).
RN   [6]
RP   PHOSPHORYLATION AT THR-45.
RX   PubMed=12392717; DOI=10.1016/s0003-9861(02)00514-3;
RA   Ishida A., Kameshita I., Okuno S., Kitani T., Fujisawa H.;
RT   "Phosphorylation of calmodulin by Ca2+/calmodulin-dependent protein kinase
RT   IV.";
RL   Arch. Biochem. Biophys. 407:72-82(2002).
RN   [7]
RP   INTERACTION WITH RRAD.
RX   PubMed=18056528; DOI=10.1161/circulationaha.107.707257;
RA   Chang L., Zhang J., Tseng Y.-H., Xie C.-Q., Ilany J., Bruning J.C., Sun Z.,
RA   Zhu X., Cui T., Youker K.A., Yang Q., Day S.M., Kahn C.R., Chen Y.E.;
RT   "Rad GTPase deficiency leads to cardiac hypertrophy.";
RL   Circulation 116:2976-2983(2007).
RN   [8]
RP   ACETYLATION AT ALA-2, AND IDENTIFICATION BY MASS SPECTROMETRY.
RA   Lubec G., Chen W.-Q.;
RL   Submitted (FEB-2007) to UniProtKB.
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-100 AND SER-102, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
RN   [10]
RP   INTERACTION WITH KIF1A.
RX   PubMed=30021165; DOI=10.1016/j.celrep.2018.06.071;
RA   Stucchi R., Plucinska G., Hummel J.J.A., Zahavi E.E., Guerra San Juan I.,
RA   Klykov O., Scheltema R.A., Altelaar A.F.M., Hoogenraad C.C.;
RT   "Regulation of KIF1A-Driven Dense Core Vesicle Transport: Ca2+/CaM Controls
RT   DCV Binding and Liprin-alpha/TANC2 Recruits DCVs to Postsynaptic Sites.";
RL   Cell Rep. 24:685-700(2018).
RN   [11]
RP   X-RAY CRYSTALLOGRAPHY (3.0 ANGSTROMS).
RX   PubMed=3990807; DOI=10.1038/315037a0;
RA   Babu Y.S., Sack J.S., Greenhough T.J., Bugg C.E., Means A.R., Cook W.J.;
RT   "Three-dimensional structure of calmodulin.";
RL   Nature 315:37-40(1985).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS).
RX   PubMed=3145979; DOI=10.1016/0022-2836(88)90608-0;
RA   Babu Y.S., Bugg C.E., Cook W.J.;
RT   "Structure of calmodulin refined at 2.2-A resolution.";
RL   J. Mol. Biol. 204:191-204(1988).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (1.90 ANGSTROMS) IN COMPLEX WITH ORAI1, AND
RP   INTERACTION WITH ORAI1.
RX   PubMed=23109337; DOI=10.1074/jbc.m112.380964;
RA   Liu Y., Zheng X., Mueller G.A., Sobhany M., DeRose E.F., Zhang Y.,
RA   London R.E., Birnbaumer L.;
RT   "Crystal structure of calmodulin binding domain of orai1 in complex with
RT   Ca2+ calmodulin displays a unique binding mode.";
RL   J. Biol. Chem. 287:43030-43041(2012).
CC   -!- FUNCTION: Calmodulin mediates the control of a large number of enzymes,
CC       ion channels, aquaporins and other proteins through calcium-binding.
CC       Among the enzymes to be stimulated by the calmodulin-calcium complex
CC       are a number of protein kinases and phosphatases. Together with CCP110
CC       and centrin, is involved in a genetic pathway that regulates the
CC       centrosome cycle and progression through cytokinesis. Mediates calcium-
CC       dependent inactivation of CACNA1C. Positively regulates calcium-
CC       activated potassium channel activity of KCNN2.
CC       {ECO:0000250|UniProtKB:P62158}.
CC   -!- SUBUNIT: Interacts with CEP97, CCP110, TTN/titin and SRY (By
CC       similarity). Interacts with MYO5A and RRAD (PubMed:18056528). Interacts
CC       with USP6; the interaction is calcium dependent (By similarity).
CC       Interacts with CDK5RAP2 (By similarity). Interacts with SCN5A (By
CC       similarity). Interacts with RYR1 (By similarity). Interacts with FCHO1
CC       (By similarity). Interacts with MIP in a 1:2 stoichiometry; the
CC       interaction with the cytoplasmic domains from two MIP subunits promotes
CC       MIP water channel closure (By similarity). Interacts with ORAI1; this
CC       may play a role in the regulation of ORAI1-mediated calcium transport
CC       (PubMed:23109337). Interacts with SYT7 (By similarity). Interacts with
CC       MYO10 and MYO1C (By similarity). Interacts with CEACAM1 (via
CC       cytoplasmic domain); this interaction is in a calcium dependent manner
CC       and reduces homophilic cell adhesion through dissociation of dimer
CC       (PubMed:8576129). Interacts with RYR2; regulates RYR2 calcium-release
CC       channel activity (By similarity). Interacts with PCP4; regulates
CC       calmodulin calcium-binding (By similarity). Interacts with the
CC       heterotetrameric KCNQ2 and KCNQ3 channel; the interaction is calcium-
CC       independent, constitutive and participates to the proper assembly of a
CC       functional heterotetrameric M channel (By similarity). Interacts with
CC       SLC9A1 in a calcium-dependent manner (By similarity). In the absence of
CC       Ca(+2), interacts with GIMAP4 (via IQ domain) (By similarity).
CC       Interacts with SCN8A; the interaction modulates the inactivation rate
CC       of SCN8A (By similarity). Interaction with KIF1A; the interaction is
CC       increased in presence of calcium and increases neuronal dense core
CC       vesicles motility (PubMed:30021165). {ECO:0000250|UniProtKB:P0DP23,
CC       ECO:0000250|UniProtKB:P0DP26, ECO:0000250|UniProtKB:P62157,
CC       ECO:0000250|UniProtKB:P62158, ECO:0000250|UniProtKB:P62204,
CC       ECO:0000269|PubMed:18056528, ECO:0000269|PubMed:23109337,
CC       ECO:0000269|PubMed:30021165, ECO:0000269|PubMed:8576129}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton, spindle. Cytoplasm,
CC       cytoskeleton, spindle pole. Note=Distributed throughout the cell during
CC       interphase, but during mitosis becomes dramatically localized to the
CC       spindle poles and the spindle microtubules. {ECO:0000250}.
CC   -!- PTM: Ubiquitination results in a strongly decreased activity.
CC       {ECO:0000250}.
CC   -!- PTM: Phosphorylation results in a decreased activity.
CC       {ECO:0000269|PubMed:12392717}.
CC   -!- MISCELLANEOUS: This protein has four functional calcium-binding sites.
CC       {ECO:0000250|UniProtKB:P0DP23}.
CC   -!- SIMILARITY: Belongs to the calmodulin family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X13933; CAA32120.1; -; mRNA.
DR   EMBL; X13931; CAA32119.1; -; Genomic_DNA.
DR   EMBL; X13932; CAA32119.1; JOINED; Genomic_DNA.
DR   EMBL; X05117; CAA32119.1; JOINED; Genomic_DNA.
DR   EMBL; AF178845; AAD55398.1; -; mRNA.
DR   PIR; S03206; MCRT.
DR   RefSeq; NP_036650.1; NM_012518.3.
DR   RefSeq; NP_059022.1; NM_017326.3.
DR   RefSeq; NP_114175.1; NM_031969.2.
DR   PDB; 1G4Y; X-ray; 1.60 A; R=2-149.
DR   PDB; 1NIW; X-ray; 2.05 A; A/C/E/G=2-149.
DR   PDB; 1QX5; X-ray; 2.54 A; B/D/I/J/K/R/T/Y=2-149.
DR   PDB; 1QX7; X-ray; 3.09 A; A/B/I/M/R=2-149.
DR   PDB; 1UP5; X-ray; 1.90 A; A/B=2-149.
DR   PDB; 2HQW; X-ray; 1.90 A; A=2-149.
DR   PDB; 2MGU; NMR; -; A=2-149.
DR   PDB; 2PQ3; X-ray; 1.30 A; A=2-77.
DR   PDB; 2YGG; X-ray; 2.23 A; B=1-149.
DR   PDB; 3B32; X-ray; 1.60 A; A=2-76.
DR   PDB; 3BXK; X-ray; 2.55 A; A/C=2-149.
DR   PDB; 3BXL; X-ray; 2.30 A; A=2-149.
DR   PDB; 3CLN; X-ray; 2.20 A; A=2-149.
DR   PDB; 3EK4; X-ray; 2.65 A; A=3-149.
DR   PDB; 3EK7; X-ray; 1.85 A; A=3-149.
DR   PDB; 3EK8; X-ray; 2.80 A; A=3-149.
DR   PDB; 3EKH; X-ray; 2.00 A; A=3-149.
DR   PDB; 3EKJ; X-ray; 2.80 A; A=3-149.
DR   PDB; 3EVR; X-ray; 2.00 A; A=3-148.
DR   PDB; 3EVU; X-ray; 1.75 A; A=3-148.
DR   PDB; 3EVV; X-ray; 2.60 A; A=3-148.
DR   PDB; 3IFK; X-ray; 2.03 A; A/B=2-91.
DR   PDB; 3SG2; X-ray; 2.00 A; A=3-149.
DR   PDB; 3SG3; X-ray; 2.10 A; A=3-149.
DR   PDB; 3SG4; X-ray; 2.40 A; A=3-149.
DR   PDB; 3SG5; X-ray; 1.90 A; A=3-149.
DR   PDB; 3SG6; X-ray; 1.70 A; A=3-149.
DR   PDB; 3SG7; X-ray; 1.90 A; A=3-149.
DR   PDB; 3SJQ; X-ray; 1.90 A; A/B=1-149.
DR   PDB; 3WLC; X-ray; 2.49 A; A=3-149.
DR   PDB; 3WLD; X-ray; 2.70 A; A=3-149.
DR   PDB; 4EHQ; X-ray; 1.90 A; A=2-149.
DR   PDB; 4G27; X-ray; 1.65 A; R=1-149.
DR   PDB; 4G28; X-ray; 1.63 A; R=1-149.
DR   PDB; 4I2Y; X-ray; 2.20 A; A/B=3-149.
DR   PDB; 4IL1; X-ray; 3.00 A; A/B/C/D=1-149.
DR   PDB; 4J9Y; X-ray; 1.51 A; R=1-149.
DR   PDB; 4J9Z; X-ray; 1.66 A; R=1-149.
DR   PDB; 4OY4; X-ray; 2.03 A; A=3-147.
DR   PDB; 4QNH; X-ray; 2.02 A; R=1-149.
DR   PDB; 4RJD; X-ray; 2.00 A; A/B=83-148.
DR   PDB; 6CZQ; X-ray; 2.20 A; R=5-148.
DR   PDB; 6DMW; EM; 4.40 A; E=1-149.
DR   PDB; 6MBA; X-ray; 1.80 A; B=1-149.
DR   PDB; 6MC9; X-ray; 3.30 A; B=1-149.
DR   PDBsum; 1G4Y; -.
DR   PDBsum; 1NIW; -.
DR   PDBsum; 1QX5; -.
DR   PDBsum; 1QX7; -.
DR   PDBsum; 1UP5; -.
DR   PDBsum; 2HQW; -.
DR   PDBsum; 2MGU; -.
DR   PDBsum; 2PQ3; -.
DR   PDBsum; 2YGG; -.
DR   PDBsum; 3B32; -.
DR   PDBsum; 3BXK; -.
DR   PDBsum; 3BXL; -.
DR   PDBsum; 3CLN; -.
DR   PDBsum; 3EK4; -.
DR   PDBsum; 3EK7; -.
DR   PDBsum; 3EK8; -.
DR   PDBsum; 3EKH; -.
DR   PDBsum; 3EKJ; -.
DR   PDBsum; 3EVR; -.
DR   PDBsum; 3EVU; -.
DR   PDBsum; 3EVV; -.
DR   PDBsum; 3IFK; -.
DR   PDBsum; 3SG2; -.
DR   PDBsum; 3SG3; -.
DR   PDBsum; 3SG4; -.
DR   PDBsum; 3SG5; -.
DR   PDBsum; 3SG6; -.
DR   PDBsum; 3SG7; -.
DR   PDBsum; 3SJQ; -.
DR   PDBsum; 3WLC; -.
DR   PDBsum; 3WLD; -.
DR   PDBsum; 4EHQ; -.
DR   PDBsum; 4G27; -.
DR   PDBsum; 4G28; -.
DR   PDBsum; 4I2Y; -.
DR   PDBsum; 4IL1; -.
DR   PDBsum; 4J9Y; -.
DR   PDBsum; 4J9Z; -.
DR   PDBsum; 4OY4; -.
DR   PDBsum; 4QNH; -.
DR   PDBsum; 4RJD; -.
DR   PDBsum; 6CZQ; -.
DR   PDBsum; 6DMW; -.
DR   PDBsum; 6MBA; -.
DR   PDBsum; 6MC9; -.
DR   SMR; P0DP29; -.
DR   STRING; 10116.ENSRNOP00000063822; -.
DR   iPTMnet; P0DP29; -.
DR   jPOST; P0DP29; -.
DR   PRIDE; P0DP29; -.
DR   Ensembl; ENSRNOT00000022603; ENSRNOP00000022603; ENSRNOG00000016770.
DR   Ensembl; ENSRNOT00000064679; ENSRNOP00000063822; ENSRNOG00000004060.
DR   GeneID; 24242; -.
DR   GeneID; 24244; -.
DR   GeneID; 50663; -.
DR   KEGG; rno:24242; -.
DR   KEGG; rno:24244; -.
DR   KEGG; rno:50663; -.
DR   CTD; 801; -.
DR   CTD; 805; -.
DR   CTD; 808; -.
DR   RGD; 2257; Calm1.
DR   KO; K02183; -.
DR   OMA; SPHESSN; -.
DR   OrthoDB; 1386217at2759; -.
DR   PRO; PR:P0DP29; -.
DR   Proteomes; UP000002494; Chromosome 1.
DR   Proteomes; UP000002494; Chromosome 6.
DR   ExpressionAtlas; P0DP29; baseline and differential.
DR   GO; GO:0034704; C:calcium channel complex; ISO:RGD.
DR   GO; GO:1902494; C:catalytic complex; ISO:RGD.
DR   GO; GO:0005623; C:cell; IEA:GOC.
DR   GO; GO:0005813; C:centrosome; ISO:RGD.
DR   GO; GO:0005737; C:cytoplasm; IDA:RGD.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0030426; C:growth cone; IDA:RGD.
DR   GO; GO:0005739; C:mitochondrion; IEA:GOC.
DR   GO; GO:0043209; C:myelin sheath; IDA:CAFA.
DR   GO; GO:0043005; C:neuron projection; IDA:RGD.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; IDA:RGD.
DR   GO; GO:0005886; C:plasma membrane; IDA:RGD.
DR   GO; GO:0032991; C:protein-containing complex; ISO:RGD.
DR   GO; GO:0030017; C:sarcomere; ISO:RGD.
DR   GO; GO:0005876; C:spindle microtubule; ISO:RGD.
DR   GO; GO:0000922; C:spindle pole; ISO:RGD.
DR   GO; GO:0008076; C:voltage-gated potassium channel complex; ISO:RGD.
DR   GO; GO:0010856; F:adenylate cyclase activator activity; ISO:RGD.
DR   GO; GO:0008179; F:adenylate cyclase binding; IDA:RGD.
DR   GO; GO:0019855; F:calcium channel inhibitor activity; ISS:UniProtKB.
DR   GO; GO:0005246; F:calcium channel regulator activity; NAS:RGD.
DR   GO; GO:0005509; F:calcium ion binding; IDA:RGD.
DR   GO; GO:0048306; F:calcium-dependent protein binding; IPI:RGD.
DR   GO; GO:0097718; F:disordered domain specific binding; ISO:RGD.
DR   GO; GO:0030234; F:enzyme regulator activity; IBA:GO_Central.
DR   GO; GO:0044325; F:ion channel binding; IDA:RGD.
DR   GO; GO:0031997; F:N-terminal myristoylation domain binding; ISO:RGD.
DR   GO; GO:0050998; F:nitric-oxide synthase binding; IDA:RGD.
DR   GO; GO:0030235; F:nitric-oxide synthase regulator activity; IDA:RGD.
DR   GO; GO:0043548; F:phosphatidylinositol 3-kinase binding; IPI:RGD.
DR   GO; GO:0019904; F:protein domain specific binding; IPI:RGD.
DR   GO; GO:0019901; F:protein kinase binding; ISO:RGD.
DR   GO; GO:0047485; F:protein N-terminus binding; IDA:RGD.
DR   GO; GO:0072542; F:protein phosphatase activator activity; ISO:RGD.
DR   GO; GO:0031432; F:titin binding; ISO:RGD.
DR   GO; GO:0031800; F:type 3 metabotropic glutamate receptor binding; IPI:RGD.
DR   GO; GO:0007190; P:activation of adenylate cyclase activity; IDA:RGD.
DR   GO; GO:0019722; P:calcium-mediated signaling; IMP:RGD.
DR   GO; GO:0005513; P:detection of calcium ion; ISO:RGD.
DR   GO; GO:0090150; P:establishment of protein localization to membrane; IMP:CAFA.
DR   GO; GO:0090151; P:establishment of protein localization to mitochondrial membrane; IMP:CAFA.
DR   GO; GO:0000086; P:G2/M transition of mitotic cell cycle; ISO:RGD.
DR   GO; GO:0000226; P:microtubule cytoskeleton organization; IBA:GO_Central.
DR   GO; GO:0060315; P:negative regulation of ryanodine-sensitive calcium-release channel activity; ISS:UniProtKB.
DR   GO; GO:0051343; P:positive regulation of cyclic-nucleotide phosphodiesterase activity; ISO:RGD.
DR   GO; GO:0043388; P:positive regulation of DNA binding; ISO:RGD.
DR   GO; GO:0051000; P:positive regulation of nitric-oxide synthase activity; IDA:RGD.
DR   GO; GO:0032516; P:positive regulation of phosphoprotein phosphatase activity; ISO:RGD.
DR   GO; GO:0035307; P:positive regulation of protein dephosphorylation; ISO:RGD.
DR   GO; GO:0060316; P:positive regulation of ryanodine-sensitive calcium-release channel activity; ISO:RGD.
DR   GO; GO:0055117; P:regulation of cardiac muscle contraction; ISO:RGD.
DR   GO; GO:0032465; P:regulation of cytokinesis; ISO:RGD.
DR   GO; GO:0002027; P:regulation of heart rate; ISO:RGD.
DR   GO; GO:1901841; P:regulation of high voltage-gated calcium channel activity; IMP:RGD.
DR   GO; GO:0010880; P:regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum; ISO:RGD.
DR   GO; GO:0060314; P:regulation of ryanodine-sensitive calcium-release channel activity; IDA:RGD.
DR   GO; GO:1901339; P:regulation of store-operated calcium channel activity; IC:RGD.
DR   GO; GO:1900242; P:regulation of synaptic vesicle endocytosis; IMP:CAFA.
DR   GO; GO:2000300; P:regulation of synaptic vesicle exocytosis; IMP:CAFA.
DR   GO; GO:0001975; P:response to amphetamine; IEP:RGD.
DR   GO; GO:0051592; P:response to calcium ion; ISO:RGD.
DR   CDD; cd00051; EFh; 2.
DR   InterPro; IPR039030; Calmodulin.
DR   InterPro; IPR011992; EF-hand-dom_pair.
DR   InterPro; IPR018247; EF_Hand_1_Ca_BS.
DR   InterPro; IPR002048; EF_hand_dom.
DR   PANTHER; PTHR23050:SF379; PTHR23050:SF379; 1.
DR   Pfam; PF13499; EF-hand_7; 2.
DR   SMART; SM00054; EFh; 4.
DR   SUPFAM; SSF47473; SSF47473; 1.
DR   PROSITE; PS00018; EF_HAND_1; 4.
DR   PROSITE; PS50222; EF_HAND_2; 4.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Calcium; Cytoplasm; Cytoskeleton;
KW   Direct protein sequencing; Isopeptide bond; Metal-binding; Methylation;
KW   Phosphoprotein; Reference proteome; Repeat; Ubl conjugation.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000269|PubMed:201628, ECO:0000269|Ref.8"
FT   CHAIN           2..149
FT                   /note="Calmodulin-1"
FT                   /id="PRO_0000439938"
FT   DOMAIN          8..43
FT                   /note="EF-hand 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   DOMAIN          44..79
FT                   /note="EF-hand 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   DOMAIN          81..116
FT                   /note="EF-hand 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   DOMAIN          117..149
FT                   /note="EF-hand 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   CA_BIND         21..32
FT                   /note="1"
FT   CA_BIND         57..68
FT                   /note="2"
FT   CA_BIND         94..105
FT                   /note="3"
FT   CA_BIND         130..141
FT                   /note="4"
FT   REGION          77..149
FT                   /note="Necessary and sufficient for interaction with PCP4"
FT                   /evidence="ECO:0000250|UniProtKB:P0DP23"
FT   MOD_RES         2
FT                   /note="N-acetylalanine"
FT                   /evidence="ECO:0000269|PubMed:201628, ECO:0000269|Ref.8"
FT   MOD_RES         22
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P0DP23"
FT   MOD_RES         45
FT                   /note="Phosphothreonine; by CaMK4"
FT                   /evidence="ECO:0000269|PubMed:12392717"
FT   MOD_RES         82
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P0DP23"
FT   MOD_RES         95
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P0DP23"
FT   MOD_RES         100
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000244|PubMed:22673903"
FT   MOD_RES         102
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:22673903"
FT   MOD_RES         111
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P0DP23"
FT   MOD_RES         116
FT                   /note="N6,N6,N6-trimethyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:201628"
FT   MOD_RES         116
FT                   /note="N6-methyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P0DP23"
FT   MOD_RES         139
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:P0DP23"
FT   CROSSLNK        22
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P0DP23"
FT   CROSSLNK        22
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P62157"
FT   HELIX           7..20
FT                   /evidence="ECO:0000244|PDB:6MBA"
FT   STRAND          25..28
FT                   /evidence="ECO:0000244|PDB:3SG6"
FT   HELIX           30..39
FT                   /evidence="ECO:0000244|PDB:3SG6"
FT   HELIX           46..54
FT                   /evidence="ECO:0000244|PDB:3SG6"
FT   STRAND          60..65
FT                   /evidence="ECO:0000244|PDB:3SG6"
FT   HELIX           66..74
FT                   /evidence="ECO:0000244|PDB:3SG6"
FT   TURN            79..81
FT                   /evidence="ECO:0000244|PDB:3SG7"
FT   HELIX           83..93
FT                   /evidence="ECO:0000244|PDB:3SG6"
FT   STRAND          98..101
FT                   /evidence="ECO:0000244|PDB:3SG6"
FT   HELIX           103..113
FT                   /evidence="ECO:0000244|PDB:3SG6"
FT   HELIX           119..129
FT                   /evidence="ECO:0000244|PDB:3SG6"
FT   STRAND          133..138
FT                   /evidence="ECO:0000244|PDB:3SG6"
FT   HELIX           139..146
FT                   /evidence="ECO:0000244|PDB:3SG6"
SQ   SEQUENCE   149 AA;  16838 MW;  6B4BC3FCDE10727B CRC64;
     MADQLTEEQI AEFKEAFSLF DKDGDGTITT KELGTVMRSL GQNPTEAELQ DMINEVDADG
     NGTIDFPEFL TMMARKMKDT DSEEEIREAF RVFDKDGNGY ISAAELRHVM TNLGEKLTDE
     EVDEMIREAD IDGDGQVNYE EFVQMMTAK
//
